Antiretroviral APOBEC3 cytidine deaminases alter HIV-1 provirus integration site profiles

Nat Commun. 2023 Jan 10;14(1):16. doi: 10.1038/s41467-022-35379-y.

Abstract

APOBEC3 (A3) proteins are host-encoded deoxycytidine deaminases that provide an innate immune barrier to retroviral infection, notably against HIV-1. Low levels of deamination are believed to contribute to the genetic evolution of HIV-1, while intense catalytic activity of these proteins can induce catastrophic hypermutation in proviral DNA leading to near-total HIV-1 restriction. So far, little is known about how A3 cytosine deaminases might impact HIV-1 proviral DNA integration sites in human chromosomal DNA. Using a deep sequencing approach, we analyze the influence of catalytic active and inactive APOBEC3F and APOBEC3G on HIV-1 integration site selections. Here we show that DNA editing is detected at the extremities of the long terminal repeat regions of the virus. Both catalytic active and non-catalytic A3 mutants decrease insertions into gene coding sequences and increase integration sites into SINE elements, oncogenes and transcription-silencing non-B DNA features. Our data implicates A3 as a host factor influencing HIV-1 integration site selection and also promotes what appears to be a more latent expression profile.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • APOBEC Deaminases / genetics
  • APOBEC Deaminases / metabolism
  • APOBEC-3G Deaminase / metabolism
  • Anti-Retroviral Agents
  • Cytidine / metabolism
  • Cytidine Deaminase / genetics
  • Cytidine Deaminase / metabolism
  • Cytosine Deaminase / genetics
  • Cytosine Deaminase / metabolism
  • HIV Infections*
  • HIV-1* / genetics
  • HIV-1* / metabolism
  • Humans
  • Proteins / metabolism
  • Virus Integration / genetics

Substances

  • Cytidine Deaminase
  • APOBEC-3G Deaminase
  • Cytosine Deaminase
  • Proteins
  • Anti-Retroviral Agents
  • Cytidine
  • APOBEC3 proteins, human
  • APOBEC Deaminases